Biophytis (EPA:ALBPS) | Finanzwire

Basculer en Français

10809	Companies
234020	Keywords
162723	Articles
125001	Press releases

Home
Companies
Biophytis

REGULATED PRESS RELEASE

published on 03/28/2025 at 22:00, 1 year 4 months ago

Biophytis announces the settlement and delivery of its €2.6 million private placement
Biophytis announces the settlement and delivery of its €2.6 million private placement. New shares admitted for trading on Euronext Growth. Maxim Group LLC and Invest Securities involved in the transaction

Private Placement Biophytis Euronext Growth Maxim Group LLC Settlement
PRESS RELEASE

published on 03/28/2025 at 21:59, 1 year 4 months ago

Biophytis announces the settlement and delivery of its €2.6 million private placement
Biophytis settles €2.6 million private placement, issuing new shares and warrants. Company specializes in age-related disease treatments

Private Placement Biophytis Warrants New Shares Age-related Diseases
BRIEF

published on 03/26/2025 at 07:40, 1 year 4 months ago

Biophytis Completes €2.6 Million Private Placement

Private Placement Biophytis Trading Capital Increase Clinical Programs
REGULATED PRESS RELEASE

published on 03/26/2025 at 07:35, 1 year 4 months ago

Biophytis announces the successful completion of a €2,6 million private placement
Biophytis successfully completes €2.6M private placement, aiming to accelerate clinical programs and partnerships, strengthen corporate purposes, and extend cash runway

Private Placement Biophytis Biotechnology Fundraising Clinical Programs
BRIEF

published on 03/24/2025 at 07:35, 1 year 4 months ago

Biophytis Reveals New Preclinical Findings on Obesity Treatment

Biophytis Obesity Treatment GLP-1 Preclinical Results Muscle Strength
REGULATED PRESS RELEASE

published on 03/24/2025 at 07:30, 1 year 4 months ago

Biophytis announces new non-clinical data further supporting its mission to pioneer the restoration of mobility in patients with obesity
Biophytis announces new preclinical study results showing combination of BIO101 and GLP-1 restores muscle strength and mobility in obesity patients. The company aims to pioneer mobility restoration in obese patients

Biophytis Preclinical Study BIO101 Obesity GLP-1
BRIEF

published on 03/17/2025 at 07:05, 1 year 4 months ago

Biophytis Publishes Promising Sarcopenia Trial Results

Biophytis Clinical Trial Sarcopenia BIO101 Phase 2 Results
REGULATED PRESS RELEASE

published on 03/17/2025 at 07:00, 1 year 4 months ago

Biophytis revolutionizes sarcopenia
Biophytis announces groundbreaking results from SARA-INT Phase II trial for BIO101 in sarcopenia, confirming Phase 3 readiness. Publication in JCSM highlights efficacy and safety

Biophytis Clinical Trial Sarcopenia Phase II SARA-INT
BRIEF

published on 03/06/2025 at 07:05, 1 year 5 months ago

Biophytis to Attend BIO-Europe Spring 2025 in Milan

Biophytis Biotechnology Drug Development BIO-Europe 2025 Aging Diseases
REGULATED PRESS RELEASE

published on 03/06/2025 at 07:00, 1 year 5 months ago

Biophytis announces its participation to the BIO-Europe Spring 2025 in Milan
Biophytis announces participation in BIO-Europe Spring 2025 in Milan. Chief Business Officer to attend meetings. Focus on lead drug candidate BIO101 in obesity and sarcopenia

Biophytis Sarcopenia BIO101 Obesity BIO-Europe Spring 2025

Accesswire

Published on 08/06/2026 at 13:00, 9 minutes ago

Azarga Metals Appoints Matt Bolu to Board of Directors
Published on 08/06/2026 at 11:00, 2 hours 9 minutes ago

Blue Lagoon Files Annual Financial Statements and Provides Comment on Temporary Cease Trade Order
Published on 08/06/2026 at 08:05, 5 hours 4 minutes ago

Tocvan Drills Significant Discovery On Mezquite Trend Gran Pilar 215M Of 0.6 G/T AU, From 36.6M Downhole
Published on 08/06/2026 at 03:35, 9 hours 34 minutes ago

Tunkillia Upgrade Drilling – 39,000m Phase 2 Complete Targeting JORC Resource Classification Upgrades; PFS Underway
Published on 08/06/2026 at 01:40, 11 hours 29 minutes ago

Taranis Identifies a Hydrothermally Altered, Sulfide-Bearing Intrusive Stock Associated with Historic Gold-Silver Occurrence and Connected to Thor

View all ACCESSWIRE

EQS Group

Published on 08/06/2026 at 12:05, 1 hour 4 minutes ago

CULTURAL DISRUPTORS AND CULINARY ICONS UNVEILED AS THE GLOBAL JURY FOR THE S.PELLEGRINO YOUNG CHEF ACADEMY COMPETITION 2026-27
Published on 08/06/2026 at 11:50, 1 hour 18 minutes ago

Cairn Homes Plc: Holding(s) in Company
Published on 08/06/2026 at 11:30, 1 hour 39 minutes ago

Partners Group to become majority shareholder in data center power solutions provider AVK and accelerate future growth
Published on 08/06/2026 at 11:05, 2 hours 4 minutes ago

ABB invests in LevelTen Energy to advance clean energy procurement
Published on 08/06/2026 at 11:05, 2 hours 4 minutes ago

IIFL Capital partners with Flytxt to leverage Agentic AI for sustainable AUM growth

Les Echos

Published on 08/06/2026 at 08:00, 5 hours 9 minutes ago

EURAZEO ENTERS INTO EXCLUSIVE DISCUSSIONS WITH PARTNERS GROUP REGARDING THE CONTEMPLATED SALE OF ITS STAKE IN AROMA-ZONE AND ITS REINVESTMENT
Published on 08/05/2026 at 18:00, 19 hours 9 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of July 31, 2026
Published on 08/05/2026 at 17:49, 19 hours 19 minutes ago

Mersen: Number of shares and voting rights as of July 31, 2026
Published on 08/05/2026 at 17:45, 19 hours 24 minutes ago

Information concerning the total number of voting rights and shares 2026 07 31
Published on 08/05/2026 at 17:45, 19 hours 24 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE